The dopamine (DA) D1-like receptor agonist SKF 38393 has been reported to impair responding for conditioned reward. SKF 38393 is a partial agonist and it is possible that the impairment occurred because it prevented endogenous DA from having its full impact on the D1-like receptor. The present experiments evaluated this possibility by examining the effects of several D1-like agonists with differing efficacy at stimulating adenylate cyclase. Male rats (n = 203) were trained in a procedure with three distinct phases. During the pre-exposure phase the rats were exposed for five 40min sessions to an operant chamber containing two levers; one produced a lights-off and the other a tone stimulus (3s). This was followed by the conditioning phase, four sessions during which the levers were removed and the rats received pairings of the lights-off stimulus (80 per day) with food, presented according to a variable time 45s schedule. The test phase included two sessions during which the levers were present and the number of responses made on each lever was calculated as a ratio of the number of responses made during pre-exposure. Drugs were administered prior to each test session. No-injection and saline groups showed a higher ratio of responding for the lights-off than the tone stimulus, indicating that the lights-off stimulus had become a conditioned reward. The full D1-like agonist SKF 82958 (0.01-1.0mg/kg, s.c.) and the partial agonists SKF 81297 (0.01-1.0mg/kg), SKF 77434 (0.01-5.0mg/kg) and CY 208-243 (0.01-1.0mg/kg) impaired responding for conditioned reward at one or more of the highest doses. Results suggest that the impairments previously seen with SKF 38393 are not attributable to the partial agonist action of that drug, and continue to support the hypothesis that responding for conditioned reward is dependent on a reward-related DA signal at the D1-like receptor.
Download full-text PDF |
Source |
---|
Neuropharmacology
January 2025
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester MN, 55905, USA; Neuroscience Program, Mayo Clinic College of Medicine and Science, MN, 55905, USA; Department of Psychiatry and Psychology, Mayo Clinic College of Medicine and Science, Rochester, MN, 59905, USA. Electronic address:
The ventral striatum is crucially involved in reward processing. The present study investigates the behavioral effects of astrocyte-specific calcium extrusion virus "CalEx" on perseverative responses in the operant five-choice serial reaction time task and ethanol-conditioned place preference. Mice were injected with CalEx via the GfaABCD promoter to extrude cytosolic calcium from astrocytes within the ventral striatum.
View Article and Find Full Text PDFHeliyon
January 2025
Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China.
The anterior cingulate cortex is responsible for multiple cognitive functions like fear, pain management, decision-making, risk and reward assessment, and memory consolidation. However, its cell-type-specific functions are not clearly understood. To reveal the selective functional role of Parvalbumin-expressing GABAergic interneurons in the ACC, we knocked down (KD) the PV gene in-vivo in rats.
View Article and Find Full Text PDFAdv Sci (Weinh)
January 2025
College of Forensic Medicine, Key Laboratory of National Health Commission for Forensic Medicine, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, 710061, China.
Lysine demethylase 7A (KDM7A) catalyzes the removal of dimethylation from histone H3 lysine 9 and lysine 27, both of which are associated with transcription repression. Previous study indicates that Kdm7a mRNA in the medial prefrontal cortex (mPFC) increases after drug exposure, yet its role in drug-related behaviors is largely unknown. In a morphine-conditioned place preference (CPP) paradigm, these findings reveal a specific increase of Kdm7a expression in the mPFC 7 days after drug withdrawal.
View Article and Find Full Text PDFNeuroscience
January 2025
Institute for Neuroscience, The University of Texas at Austin, Austin, TX, USA; Waggoner Center for Alcohol & Addiction Research, The University of Texas at Austin, Austin, TX, USA; Department of Neuroscience, The University of Texas at Austin, Austin, TX, USA; Department of Neurology, Dell Medical School, The University of Texas at Austin, Austin, TX, USA. Electronic address:
While our understanding of the neurobiological mechanisms underlying cocaine and opiate reward has historically been dopamine-focused, evidence from genetic and pharmacological approaches indicates that µ-opioid receptors (MORs) in the striatum are important contributors. Within the striatum, MORs are expressed in both dopamine D1-receptor and D2-receptor expressing GABAergic medium spiny neurons (MSNs), as well as in interneurons and various afferents. Thus, it remains unclear how these distinct MOR populations regulate drug reward.
View Article and Find Full Text PDFPsychopharmacology (Berl)
January 2025
Department of Psychology, University of New England, Biddeford, ME, USA.
Rationale And Objectives: In vivo receptor interactions vary as a function of behavioral endpoint, with key differences between reflexive and non-reflexive measures that assess the motivational aspects of pain and pain relief. There have been no assessments of D dopamine agonist / mu opioid receptor (MOR) agonist interactions in non-reflexive behavioral measures of pain. We examined the hypothesis that D/MOR mixtures show enhanced effectiveness in blocking pain depressed behaviors while showing decreased side effects such as sedation and drug reward.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!